基层和选民抱怨帕尔马公司的影响，以提高药物成本。 “2003年医疗保险处方药物改进和现代化法”的通过显示价格谈判如何帮助管理人员获得14％的好处（Gray，Hanson和Kousser 29）。因此，人们继续质疑说客的努力。毒品的高价格被认为是游说的根本原因。在这种情况下，人们间接游说他们的代表，以控制药品的猖獗影响，以保持信誉。
One of the most important lobbying group is the Pharmaceuticals. They are responsible for the health cost and health care in the nation. These pharmaceutical companies spent millions to pass a legislations. Each big pharmaceutical company spends around 100 million to assuage the government for their cause. There are more than 1274 lobbyists who are registered in the Washington DC to make their cause. It is imperative for the lobbying groups to state the exact amount they spend on the lobbying efforts. These lobbyists and the lobbying groups have to maintain transparency of their operations. This is a controversial issue, and there is obscurity of the processes that have been mentioned as issues by the people.
The grassroots and the electorate complain about the influence of the Parma companies to drive up drug costs. The passage of “ Medicare Prescription Drug Improvement and Modernization Act of 2003” shows how the price negotiations helped the managers gain benefits of 14% (Gray, Hanson and Kousser 29). Hence the people continue to question the efforts of the lobbyists. The high prices of drugs have been considered to be the root causes of the lobbying. In this situation there is indirect lobbying by the people toward their representative to control the rampant impact of the pharmaceuticals to maintain credibility.